查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1623514

按类型、应用程式、最终用户、地区、范围和预测划分的全球尿液检测市场规模

Global Urinalysis Market Size By Type (Instruments, Consumables), By Application (Disease Screening, Pregnancy and Fertility Testing), By End-User (Clinical Laboratories, Hospitals, Home Care), By Geographic Scope and Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格
简介目录

尿液检测市场规模及预测

2023年尿液检测市场规模为20.7亿美元，预计到2031年将达到39.1亿美元，2024年至2031年复合年增长率为8.30%。尿液分析是指透过检测尿液样整体评估健康状况、检测疾病和监测各种医疗状况的诊断过程。此检测广泛用于临床实验室和医疗机构，用于诊断泌尿道感染、肾臟疾病、糖尿病和肝损伤等疾病。

尿液检测的未来充满希望，技术的进步带来了检测方法的创新，包括即时检测设备和自动尿液检测系统的开发。

全球尿液检测市场动态

塑造全球尿液检测市场的主要市场动态是：

主要市场推动因素

泌尿道感染 (UTI) 的发生率增加：

全球每年约发生 1.5 亿例泌尿道感染，因此对尿液检测产生了巨大的需求，以有效诊断和管理这些疾病。

糖尿病盛行率增加：

截至 2021 年，全球估计有 5.37 亿成年人患有糖尿病，这增加了定期尿液检测以监测血糖水平和预防併发症的需求，进一步推动了市场成长。

技术进步：

到 2025 年，全球即时检测设备市场预计将达到 606 亿美元，推动尿液检测技术的创新并扩大其在各种医疗保健环境中的应用。

强调预防保健：

到 2022 年，全球医疗保健支出预计将达到 10 兆美元，各国政府和卫生组织越来越多地推广预防性医疗保健。

主要课题

准确性和可靠性问题：

由于人为错误或样本处理不当导致的结果变化可能会影响尿液检测的准确性，并对临床决策带来课题。

遵守法规：

严格的诊断测试监管标准和指南可能会使新尿液检测设备和技术的审批过程变得复杂。

先进技术成本高：

自动化先进尿液检测系统的实施可能会因其高昂的成本而受到阻碍，这限制了小型医疗机构的使用。

新兴市场认知度低：

特别是在新兴市场，人们往往缺乏对尿液检测在医疗保健中重要性的认识和教育，这可能会限制市场的成长。

主要趋势：

人工智慧（AI）整合：

将人工智慧和机器学习演算法纳入尿液检测过程可增强结果解释、提高诊断准确性并简化工作流程。

家庭测试的兴起：

消费者对家庭健康监测解决方案的需求不断增长，推动了易于使用的尿液检测套件的开发，这些套件可以在舒适的家中进行。

个人化医疗的方法：

个人化医疗的趋势日益增长，尿液检测可以整合到量身定制的医疗计划中，从而实现更好的疾病管理和监测。

扩展远距医疗服务：

远距医疗平台的兴起正在促进远距咨询和监测，改善尿液分析服务的可近性，并能够及时介入和管理健康状况。

目录

第1章 全球尿液检测市场简介

  • 市场定义
  • 市场细分
  • 调查日程
  • 先决条件
  • 限制

第2章 验证市场研究研究方法

  • 数据挖掘
  • 数据三角测量
  • 自下而上的方法
  • 自上而下的方法
  • 调查流程
  • 业界专家的重要见解
  • 数据源

第3章 执行摘要

  • 市场概况
  • 生态製图
  • 绝对的获利机会
  • 市场吸引力
  • 全球尿液检测市场按地区分析
  • 全球尿液检测市场：按类型
  • 全球尿液检测市场：依应用分类
  • 全球尿液检测市场：依最终用户分类
  • 未来市场机会
  • 世界市场区隔
  • 产品生命线

第4章 全球尿液检测市场展望

  • 尿液检测的全球演变
  • 促进因素
  • 阻碍因素
  • 机会
  • 波特的五力模型
  • 价值链分析
  • 价格分析
  • 宏观经济分析

第5章全球尿液检测市场：依类型

  • 概述
  • 药筒和胶囊
  • 注射器过滤器
  • 瓶顶真空过滤器
  • 其他

第6章全球尿液检测市场（按应用）

  • 概述
  • 用具
  • 消耗品

第7章全球尿液检测市场：依最终用户分类

  • 概述
  • 临床实验室
  • 医院
  • 家庭医疗
  • 其他

第8章全球尿液检测市场：按地区

  • 概述
  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲
  • 中东/非洲
    • 阿拉伯联合酋长国
    • 沙乌地阿拉伯
    • 南非
    • 其他中东和非洲

第9章 全球尿液检测市场竞争格局

  • 概述
  • 企业市场排名
  • 重大发展
  • 公司区域足迹
  • 按行业划分的企业足迹
  • ACE矩阵

第10章 公司简介

  • Cardinal Health
  • Roche Diagnostics
  • Sysmex Corporation
  • Beckman Coulter
  • Arkray Inc.Abbott
  • Siemens Healthcare GmbH
  • ACON Laboratories
  • Shenzhen Mindray Bio-Medical Electronics
  • F. Hoffmann-La Roche
  • Quidel Corporation
  • Bio-Rad Laboratories
  • Urit Medical Electronics
  • 77 Elektronika Kft.
  • Mindray Medical International Limited

第 11 章 经验证的市场情报

  • 关于经过验证的市场情报
  • 动态资料视觉化
简介目录
Product Code: 23989

Urinalysis Market Size and Forecast

Urinalysis Market size was valued at USD 2.07 Billion in 2023 and is projected to reach USD 3.91 Billion by 2031 , growing at a CAGR of 8.30% from 2024 to 2031. urinalysis refers to a diagnostic process that examines urine samples to assess health status, detect diseases, and monitor various medical conditions. This analysis is widely utilized in clinical laboratories and healthcare settings for diagnosing conditions such as urinary tract infections, kidney diseases, diabetes, and liver disorders.

The future of urinalysis is promising, with advancements in technology driving innovation in testing methods, including the development of point-of-care testing devices and automated urinalysis systems.

Global Urinalysis Market Dynamics

The key market dynamics that are shaping the global urinalysis market include:

Key Market Drivers

Rising Incidence of Urinary Tract Infections (UTIs):

Approximately 150 million urinary tract infections occur globally each year, creating a significant demand for urinalysis to diagnose and manage these conditions effectively.

Growing Prevalence of Diabetes:

With an estimated 537 million adults worldwide living with diabetes as of 2021, the need for regular urinalysis to monitor glucose levels and prevent complications is increasing, further driving market growth.

Technological Advancements:

The global market for point-of-care testing devices is projected to reach $60.6 billion by 2025, fostering innovation in urinalysis technology and expanding its applications in various healthcare settings.

Emphasis on Preventive Healthcare:

Governments and health organizations are increasingly promoting preventive healthcare measures, with global healthcare expenditure projected to reach $10 trillion by 2022, which supports the growth of routine diagnostic tests, including urinalysis.

Key Challenges

Accuracy and Reliability Concerns:

Variability in results due to human error or improper sample handling can affect the accuracy of urinalysis, posing challenges in clinical decision-making.

Regulatory Compliance:

Stringent regulatory standards and guidelines for diagnostic tests can complicate the approval process for new urinalysis devices and technologies.

High Cost of Advanced Technologies:

The adoption of automated and advanced urinalysis systems can be hindered by their high costs, limiting access for smaller healthcare facilities.

Limited Awareness in Emerging Markets:

There is often a lack of awareness and education regarding the importance of urinalysis in healthcare, particularly in developing regions, which can restrict market growth.

Key Trends:

Integration of Artificial Intelligence (AI):

The incorporation of AI and machine learning algorithms into urinalysis processes is enhancing the interpretation of results, improving diagnostic accuracy, and streamlining workflows.

Rise of Home-Based Testing:

Increasing consumer demand for at-home health monitoring solutions is leading to the development of user-friendly urinalysis kits that allow individuals to conduct tests in the comfort of their homes.

Personalized Medicine Approaches:

There is a growing trend towards personalized medicine, where urinalysis is being integrated into tailored healthcare plans, enabling better disease management and monitoring.

Expansion of Telehealth Services:

The rise of telehealth platforms is facilitating remote consultations and monitoring, increasing the accessibility of urinalysis services and allowing for timely intervention and management of health conditions.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Urinalysis Market Regional Analysis

Here is a more detailed regional analysis of the global urinalysis market:

North America:

North America is the dominant region in the global urinalysis market, accounting for a significant share due to its well-established healthcare infrastructure, advanced diagnostic technologies, and high awareness of preventive healthcare. The region's strong emphasis on early disease detection and management contributes to the widespread adoption of urinalysis tests in clinical settings. According to the Centers for Disease Control and Prevention (CDC), approximately 70% of all healthcare decisions are based on laboratory test results, highlighting the critical role of urinalysis in patient care.

The presence of major market players, robust research and development activities, and a strong regulatory framework further enhance North America's market position. The U.S. Food and Drug Administration (FDA) has approved numerous innovative urinalysis products, ensuring that healthcare providers have access to advanced testing solutions. The region's focus on personalized medicine and rapid technological advancements, including point-of-care testing, also bolster the growth of the urinalysis market.

Asia Pacific:

The Asia Pacific region is the fastest-growing market for urinalysis, driven by a combination of increasing healthcare expenditures, a rising population, and growing awareness of preventive healthcare measures. Rapid urbanization and economic growth in countries like China and India have led to a surge in demand for diagnostic testing services, including urinalysis. According to the World Health Organization (WHO), healthcare spending in Asia Pacific is projected to reach $2.4 trillion by 2025, reflecting a strong commitment to improving healthcare access and quality.

The rising prevalence of lifestyle-related diseases, such as diabetes, hypertension, and obesity, is further propelling the demand for urinalysis in the region. For instance, the International Diabetes Federation (IDF) estimates that the number of adults with diabetes in the Asia Pacific region will rise to over 200 million by 2030, necessitating regular monitoring through urinalysis. This growing disease burden creates significant opportunities for market players to introduce innovative testing solutions tailored to the region's specific health challenges.

Global Urinalysis Market Segmentation Analysis

The Global Urinalysis Market is segmented on the basis of By Type, By Application, By End User and By Geography.

Urinalysis Market, By Type

  • Instruments
  • Consumables

Based on Type, the Global Urinalysis Market is segmented into Instruments and Consumables. The Instruments is the dominate segment due to the widespread adoption of automated urinalysis systems and analyzers in hospitals and diagnostic laboratories. These instruments offer enhanced accuracy and efficiency in urine testing, making them a crucial part of the diagnostic process. However, the consumables segment is the fastest-growing, driven by the rising demand for test strips, reagents, and disposable items used in both traditional and point-of-care testing.

Urinalysis Market, By Application

  • Disease Screening
  • Pregnancy and Fertility Kits

Based on Application, the Global Urinalysis Market is segmented into Disease Screening and Pregnancy & Fertility Kits. The disease screening segment is the dominant segment, driven by its widespread use in detecting conditions such as urinary tract infections, kidney disorders, and diabetes. On the other hand, the pregnancy and fertility kits segment is the fastest-growing, owing to the increasing demand for at-home testing kits that offer convenience and privacy.

Urinalysis Market, By End User

  • Clinical Laboratories
  • Hospitals
  • Home Care

Based on End User, the Global Urinalysis Market is segmented into Disease Screening and Pregnancy & Fertility Kits. The clinical laboratories is the dominating segment due to the widespread use of advanced diagnostic equipment and the high volume of tests conducted in these facilities. On the other hand, the home care segment is the fastest-growing, driven by the increasing demand for at-home diagnostic solutions and the rise of point-of-care testing.

Urinalysis Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Based on the Geography, the Global Urinalysis Market are classified into North America, Europe, Asia Pacific, and Rest of World. North America is the dominant region in the global urinalysis market, accounting for a significant share due to its well-established healthcare infrastructure, advanced diagnostic technologies, and high awareness of preventive healthcare. The Asia Pacific region is the fastest-growing market for urinalysis, driven by a combination of increasing healthcare expenditures, a rising population, and growing awareness of preventive healthcare measures.

Key Players

  • The "Global Urinalysis Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market
  • Siemens Healthineers, Roche Diagnostics, Abbott Laboratories, Danaher Corporation, Thermo Fisher Scientific, Bayer AG, F. Hoffmann-La Roche Ltd, Beckman Coulter Life Sciences, Alfa Wassermann Inc., EKF Diagnostics, Trinity Biotech plc, Arkray, Mindray Medical International Limited, and more.
  • Our
  • market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.
  • Global Urinalysis Market: Recent Developments
  • In August 2023 Siemens Healthineers announced its acquisition of a cutting-edge urinalysis technology firm focused on developing point-of-care testing solutions.
  • In July 2023 Becton, Dickinson and Company (BD) launched a new line of enhanced urinalysis reagents, designed to improve the sensitivity and specificity of urinalysis tests.
  • In June 2023 Abbott announced a strategic partnership with a HealthTech startup specializing in digital health solutions for urinalysis. This collaboration aims to develop a mobile application that allows patients to conduct at-home urinalysis tests and receive real-time feedback on their results.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL URINALYSIS MARKET

  • 1.1 Market Definition
  • 1.2 Market Segmentation
  • 1.3 Research Timelines
  • 1.4 Assumptions
  • 1.5 Limitations

2 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 2.1 Data Mining
  • 2.2 Data Triangulation
  • 2.3 Bottom-Up Approach
  • 2.4 Top-Down Approach
  • 2.5 Research Flow
  • 2.6 Key Insights from Industry Experts
  • 2.7 Data Sources

3 EXECUTIVE SUMMARY

  • 3.1 Market Overview
  • 3.2 Ecology Mapping
  • 3.3 Absolute Market Opportunity
  • 3.4 Market Attractiveness
  • 3.5 Global Urinalysis Market Geographical Analysis (CAGR %)
  • 3.6 Global Urinalysis Market, By Type (USD Million)
  • 3.7 Global Urinalysis Market, By Application (USD Million)
  • 3.8 Global Urinalysis Market, By End-User (USD Million)
  • 3.9 Future Market Opportunities
  • 3.10 Global Market Split
  • 3.11 Product Life Line

4 GLOBAL URINALYSIS MARKET OUTLOOK

  • 4.1 Global Urinalysis Evolution
  • 4.2 Drivers
    • 4.2.1 Driver 1
    • 4.2.2 Driver 2
  • 4.3 Restraints
    • 4.3.1 Restraint 1
    • 4.3.2 Restraint 2
  • 4.4 Opportunities
    • 4.4.1 Opportunity 1
    • 4.4.2 Opportunity 2
  • 4.5 Porters Five Force Model
  • 4.6 Value Chain Analysis
  • 4.7 Pricing Analysis
  • 4.8 Macroeconomic Analysis

5 GLOBAL URINALYSIS MARKET, BY TYPE

  • 5.1 Overview
  • 5.2 Cartridges & Capsules
  • 5.3 Syringe Filters
  • 5.4 Bottle-Top Vacuum Filters
  • 5.5 Others

6 GLOBAL URINALYSIS MARKET, BY APPLICATION

  • 6.1 Overview
  • 6.2 Instruments
  • 6.3 Consumables

7 GLOBAL URINALYSIS MARKET, BY END-USER

  • 7.1 Overview
  • 7.2 Clinical Laboratories
  • 7.3 Hospitals
  • 7.4 Home Care
  • 7.5 Others

8 GLOBAL URINALYSIS MARKET, BY GEOGRAPHY

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 U.K.
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Argentina
    • 8.5.3 Rest of Latin America
  • 8.6 Middle-East and Africa
    • 8.6.1 UAE
    • 8.6.2 Saudi Arabia
    • 8.6.3 South Africa
    • 8.6.4 Rest of Middle-East and Africa

9 GLOBAL URINALYSIS MARKET COMPETITIVE LANDSCAPE

  • 9.1 Overview
  • 9.2 Company Market Ranking
  • 9.3 Key Developments
  • 9.4 Company Regional Footprint
  • 9.5 Company Industry Footprint
  • 9.6 ACE Matrix

10 COMPANY PROFILES

  • 10.1 Cardinal Health
    • 10.1.1 Company Overview
    • 10.1.2 Company Insights
    • 10.1.3 Product Benchmarking
    • 10.1.4 Key Development
    • 10.1.5 Winning Imperatives
    • 10.1.6 Current Focus & Strategies
    • 10.1.7 Threat from Competition
    • 10.1.8 SWOT Analysis
  • 10.2 Roche Diagnostics
    • 10.2.1 Company Overview
    • 10.2.2 Company Insights
    • 10.2.3 Product Benchmarking
    • 10.2.4 Key Development
    • 10.2.5 Winning Imperatives
    • 10.2.6 Current Focus & Strategies
    • 10.2.7 Threat from Competition
    • 10.2.8 SWOT Analysis
  • 10.3 Sysmex Corporation
    • 10.3.1 Company Overview
    • 10.3.2 Company Insights
    • 10.3.3 Product Benchmarking
    • 10.3.4 Key Development
    • 10.3.5 Winning Imperatives
    • 10.3.6 Current Focus & Strategies
    • 10.3.7 Threat from Competition
    • 10.3.8 SWOT Analysis
  • 10.4 Beckman Coulter
    • 10.4.1 Company Overview
    • 10.4.2 Company Insights
    • 10.4.3 Product Benchmarking
    • 10.4.4 Key Development
    • 10.4.5 Winning Imperatives
    • 10.4.6 Current Focus & Strategies
    • 10.4.7 Threat from Competition
    • 10.4.8 SWOT Analysis
  • 10.5 Arkray Inc.Abbott
    • 10.5.1 Company Overview
    • 10.5.2 Company Insights
    • 10.5.3 Product Benchmarking
    • 10.5.4 Key Development
    • 10.5.5 Winning Imperatives
    • 10.5.6 Current Focus & Strategies
    • 10.5.7 Threat from Competition
    • 10.5.8 SWOT Analysis
  • 10.6 Siemens Healthcare GmbH
    • 10.6.1 Company Overview
    • 10.6.2 Company Insights
    • 10.6.3 Product Benchmarking
    • 10.6.4 Key Development
    • 10.6.5 Winning Imperatives
    • 10.6.6 Current Focus & Strategies
    • 10.6.7 Threat from Competition
    • 10.6.8 SWOT Analysis
  • 10.7 ACON Laboratories
    • 10.7.1 Company Overview
    • 10.7.2 Company Insights
    • 10.7.3 Product Benchmarking
    • 10.7.4 Key Development
    • 10.7.5 Winning Imperatives
    • 10.7.6 Current Focus & Strategies
    • 10.7.7 Threat from Competition
    • 10.7.8 SWOT Analysis
  • 10.8 Shenzhen Mindray Bio-Medical Electronics
    • 10.8.1 Company Overview
    • 10.8.2 Company Insights
    • 10.8.3 Product Benchmarking
    • 10.8.4 Key Development
    • 10.8.5 Winning Imperatives
    • 10.8.6 Current Focus & Strategies
    • 10.8.7 Threat from Competition
    • 10.8.8 SWOT Analysis
  • 10.9 F. Hoffmann-La Roche
    • 10.9.1 Company Overview
    • 10.9.2 Company Insights
    • 10.9.3 Product Benchmarking
    • 10.9.4 Key Development
    • 10.9.5 Winning Imperatives
    • 10.9.6 Current Focus & Strategies
    • 10.9.7 Threat from Competition
    • 10.9.8 SWOT Analysis
  • 10.10 Quidel Corporation
    • 10.10.1 Company Overview
    • 10.10.2 Company Insights
    • 10.10.3 Product Benchmarking
    • 10.10.4 Key Development
    • 10.10.5 Winning Imperatives
    • 10.10.6 Current Focus & Strategies
    • 10.10.7 Threat from Competition
    • 10.10.8 SWOT Analysis
  • 10.11 Bio-Rad Laboratories
    • 10.11.1 Company Overview
    • 10.11.2 Company Insights
    • 10.11.3 Product Benchmarking
    • 10.11.4 Key Development
    • 10.11.5 Winning Imperatives
    • 10.11.6 Current Focus & Strategies
    • 10.11.7 Threat from Competition
    • 10.11.8 SWOT Analysis
  • 10.12 Urit Medical Electronics
    • 10.12.1 Company Overview
    • 10.12.2 Company Insights
    • 10.12.3 Product Benchmarking
    • 10.12.4 Key Development
    • 10.12.5 Winning Imperatives
    • 10.12.6 Current Focus & Strategies
    • 10.12.7 Threat from Competition
    • 10.12.8 SWOT Analysis
  • 10.13 77 Elektronika Kft.
    • 10.13.1 Company Overview
    • 10.13.2 Company Insights
    • 10.13.3 Product Benchmarking
    • 10.13.4 Key Development
    • 10.13.5 Winning Imperatives
    • 10.13.6 Current Focus & Strategies
    • 10.13.7 Threat from Competition
    • 10.13.8 SWOT Analysis
  • 10.14 Mindray Medical International Limited
    • 10.14.1 Company Overview
    • 10.14.2 Company Insights
    • 10.14.3 Product Benchmarking
    • 10.14.4 Key Development
    • 10.14.5 Winning Imperatives
    • 10.14.6 Current Focus & Strategies
    • 10.14.7 Threat from Competition
    • 10.14.8 SWOT Analysis

11. VERIFIED MARKET INTELLIGENCE

  • 11.1 About Verified Market Intelligence
  • 11.2 Dynamic Data Visualization